There’s more to the quest of fostering diversity, equity, and inclusion in the delivery of clinical research opportunities than just reaching race/ethnicity-, gender-, and age-related goals for patient recruitment. For example, geographic diversity can also be
Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development February 22, 2022 February is Rare Disease Month—an important time when the rare disease community comes together to raise awareness and advocate
By Harsha Rajasimha, PhD, Founder and CEO, Jeeva Informatics Solutions Inc. www.jeevatrials.com To say that COVID-19 has been a challenge to healthcare systems around the world is a gross understatement. The pandemic has also been very
Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge and finding ways to minimize it
The loss of his daughter to a rare congenital disorder in the United States and the passing of his younger brother in India from complications arising from juvenile diabetes had a profound effect on Dr. Harsha
The growing use of decentralized clinical trials has raised serious concerns regarding verification of patient comprehension and proper informed consent. The solution, says Dr. Harsha Rajasimha of Jeeva Informatics, is to leverage the full potential of
Almost everything went online due to the COVID-19 pandemic, from remote collaboration with coworkers to ordering groceries and conducting online classes. But unlike other industries that have responded rapidly to COVID-19, clinical trials have been slower
Diversity is a growing concern in all aspects of modern life, but the ramifications of this disparity in health care can have life threatening consequences. According to data from the FDA, African Americans are only 5%
MANASSAS, VA. (PRWEB) DECEMBER 01, 2021 The ongoing COVID-19 pandemic ranks as perhaps the most serious global health crisis of the past hundred years. Worldwide, to date there have been almost 262 million recorded cases and
IRBs are seeing a surge in study protocols that include remote recruitment, consent, and participation, raising ethical and regulatory considerations for investigators. “We are seeing more requests for remote recruitment and consent to allow for continued
